149 related articles for article (PubMed ID: 9650856)
1. Functional interactions of L-162,313 with angiotensin II receptor subtypes and mutants.
Vianello B; Clauser E; Corvol P; Monnot C
Eur J Pharmacol; 1998 Apr; 347(1):113-8. PubMed ID: 9650856
[TBL] [Abstract][Full Text] [Related]
2. Interaction of a non-peptide agonist with angiotensin II AT1 receptor mutants.
Costa-Neto CM; Miyakawa AA; Pesquero JB; Oliveira L; Hjorth SA; Schwartz TW; Paiva AC
Can J Physiol Pharmacol; 2002 May; 80(5):413-7. PubMed ID: 12056547
[TBL] [Abstract][Full Text] [Related]
3. Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.
Perlman S; Schambye HT; Rivero RA; Greenlee WJ; Hjorth SA; Schwartz TW
J Biol Chem; 1995 Jan; 270(4):1493-6. PubMed ID: 7829475
[TBL] [Abstract][Full Text] [Related]
4. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants.
Monnot C; Bihoreau C; Conchon S; Curnow KM; Corvol P; Clauser E
J Biol Chem; 1996 Jan; 271(3):1507-13. PubMed ID: 8576145
[TBL] [Abstract][Full Text] [Related]
5. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
[TBL] [Abstract][Full Text] [Related]
6. Internalization of the rat AT1a and AT1b receptors: pharmacological and functional requirements.
Conchon S; Monnot C; Teutsch B; Corvol P; Clauser E
FEBS Lett; 1994 Aug; 349(3):365-70. PubMed ID: 8050598
[TBL] [Abstract][Full Text] [Related]
7. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium.
Lenz O; Schmid B; Kilter H; La Rosée K; Flesch M; Kuhn-Regnier F; Südkamp M; Böhm M
Eur J Pharmacol; 1995 Dec; 294(1):17-27. PubMed ID: 8788412
[TBL] [Abstract][Full Text] [Related]
9. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor subtypes and contractile responses in portal vein smooth muscle.
Pelet C; Mironneau C; Rakotoarisoa L; Neuilly G
Eur J Pharmacol; 1995 Jun; 279(1):15-24. PubMed ID: 7556378
[TBL] [Abstract][Full Text] [Related]
11. Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan.
Ji H; Leung M; Zhang Y; Catt KJ; Sandberg K
J Biol Chem; 1994 Jun; 269(24):16533-6. PubMed ID: 8206967
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
Chang RS; Lotti VJ; Chen TB; O'Malley SS; Bendesky RJ; Kling PJ; Kivlighn SD; Siegl PK; Ondeyka D; Greenlee WJ
Eur J Pharmacol; 1995 Dec; 294(2-3):429-37. PubMed ID: 8750703
[TBL] [Abstract][Full Text] [Related]
13. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
[TBL] [Abstract][Full Text] [Related]
14. Evidence that [Sar1]angiotensin II behaves differently from angiotensin II at angiotensin AT1 receptors in rabbit aorta.
Liu YJ
Eur J Pharmacol; 1993 Apr; 235(1):9-15. PubMed ID: 8519284
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor in the heart of Bothrops jararaca snake.
Breno MC; Porto CS; Picarelli ZP
Eur J Pharmacol; 2001 Apr; 417(1-2):27-35. PubMed ID: 11301056
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
18. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
19. Properties of AT1a and AT1b angiotensin receptors expressed in adrenocortical Y-1 cells.
Tian Y; Baukal AJ; Sandberg K; Bernstein KE; Balla T; Catt KJ
Am J Physiol; 1996 May; 270(5 Pt 1):E831-9. PubMed ID: 8967472
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
